当前位置: 首页 >> 检索结果
共有 145288 条符合本次的查询结果, 用时 1.4800244 秒

221. On lines, distractions, and the pursuit of positive change - Author's reply.

作者: Seye Abimbola.
来源: Lancet. 2025年405卷10496期2201-2202页

222. Claw hand as a result of Mannerist convention - Author's reply.

作者: Alexis Demas.
来源: Lancet. 2025年405卷10496期2200-2201页

223. Claw hand as a result of Mannerist convention.

作者: Nicolas Kluger.;Brian Hurwitz.;Bertrand Lefrère.
来源: Lancet. 2025年405卷10496期2199-2200页

224. Claw hand as a result of Mannerist convention.

作者: Philippe Charlier.;Saudamini Deo.
来源: Lancet. 2025年405卷10496期2199页

225. Africa's role in the WHO Pandemic Agreement.

作者: Nelson Aghogho Evaborhene.
来源: Lancet. 2025年405卷10496期2198-2199页

226. One Health: a key element in the WHO Pandemic Agreement.

作者: Xiao-Xi Zhang.;Xiao-Kui Guo.;Xiao-Nong Zhou.
来源: Lancet. 2025年405卷10496期2197-2198页

227. Violence-related deaths in Nigeria: a public health crisis.

作者: Faithful Miebaka Daniel.;Nimnan Famak Tyem.;Bonaventure Michael Ukoaka.;Geneva Cosico Magsino.;Feyi Ayanlowo.
来源: Lancet. 2025年405卷10496期2197页

228. Reinforcing resilience: confronting the consequences of global malaria aid cuts in Africa.

作者: Yap Boum.;Ngozi Adaeze Erondu.
来源: Lancet. 2025年405卷10496期2184-2186页

229. KOMET in the landscape of MEK inhibitor clinical trials for plexiform neurofibromas.

作者: Carlos G Romo.;Christine A Pratilas.
来源: Lancet. 2025年405卷10496期2182-2184页

230. Targeting the glucocorticoid receptor in relapsed ovarian cancer: a new pathway and standard treatment option in ovarian cancer.

作者: Philipp Harter.;Frederik Marmé.
来源: Lancet. 2025年405卷10496期2180-2182页

231. The mpox response: African leadership, global responsibility.

作者: The Lancet.
来源: Lancet. 2025年405卷10496期2179页

232. Community-based mentoring to reduce maternal and perinatal mortality in adolescent pregnancies in Sierra Leone (2YoungLives): a pilot cluster-randomised controlled trial.

作者: Cristina Fernandez Turienzo.;Lucy November.;Mangenda Kamara.;Osman Conteh.;Philemon Kamara.;Appiah M Kingsford.;Peter J S Koroma.;Michael Munu.;Alexandra E Ridout.;Betty Sam.;Paul T Seed.;Suzanne Thomas.;Prince T Williams.;Andrew H Shennan.;Jane Sandall.; .
来源: Lancet. 2025年405卷10497期2302-2312页
Sierra Leone has very high maternal and neonatal mortality rates, and a large proportion of these deaths occur in adolescents, a particularly vulnerable group, and is usually driven by poverty, lack of education, and sparse employment opportunities. We evaluated the feasibility and potential effects of a community-based mentoring intervention from pregnancy up to 1 year after birth to inform a subsequent larger trial aiming to reduce mortality among adolescent girls and their newborns (2YoungLives).

233. Thyroidectomy with or without postoperative radioiodine for patients with low-risk differentiated thyroid cancer in the UK (IoN): a randomised, multicentre, non-inferiority trial.

作者: Ujjal Mallick.;Kate Newbold.;Matthew Beasley.;Kate Garcez.;Jonathan Wadsley.;Sarah J Johnson.;Tim Stephenson.;Mark Gaze.;Andrew Goodman.;Sarah Jefferies.;Suganya Sivabalasingham.;Nicholas Slevin.;David P Wilkinson.;Elena Macias-Fernandez.;Danielle Power.;Tom Roques.;Lesley Speed.;Christopher Nutting.;George Mochloulis.;Georgina Gerrard.;Charles Candish.;Sally Morgan.;Devashish Tripathi.;Peter Truran.;Claire Arthur.;Andrzej Wieczorek.;Krishnaswamy Madhavan.;Jillian Maclean.;David Boote.;Dae Kim.;Abigail Pascoe.;Gayani Pitiyage.;Sharon Forsyth.;Emily Ambrose.;Elizabeth Chang.;Kate Farnell.;Allan Hackshaw.
来源: Lancet. 2025年406卷10498期52-62页
Patients with differentiated thyroid cancer can often be treated with postoperative radioiodine (also called radioiodine ablation) after total thyroidectomy. The IoN trial was designed to assess whether recurrence-free survival was non-inferior after no ablation compared with ablation in patients with low-risk differentiated thyroid cancer.

234. Improving children's lives-the case for universality.

作者: Michael Marmot.
来源: Lancet. 2025年

235. A community-based landmark trial to save the lives of pregnant adolescents and their newborns in sub-Saharan Africa.

作者: Ellen Hodnett.
来源: Lancet. 2025年405卷10497期2258-2259页

236. Practice-changing evidence for low-risk differentiated thyroid cancer.

作者: Dana M Hartl.
来源: Lancet. 2025年406卷10498期5-6页

237. Tom Shakespeare: advocating for people with disabilities.

作者: Aarathi Prasad.
来源: Lancet. 2025年

238. Cancer vaccines and the future of immunotherapy.

作者: Orrin Pail.;Matthew J Lin.;Theodora Anagnostou.;Brian D Brown.;Joshua D Brody.
来源: Lancet. 2025年406卷10499期189-202页
Vaccines have had a major impact on the control of infectious disease, most recently by helping to combat the COVID-19 pandemic. Prophylactic cancer vaccines have prevented several malignancies by protecting against cancer-causing pathogens. By contrast, therapeutic vaccines training the immune system to eliminate established tumours are now showing real promise in clinical settings. In the adjuvant setting, vaccines against melanoma and pancreatic cancer appear to be reducing minimal residual disease and relapse. In the macrometastatic setting, in-situ vaccines have induced systemic regressions in advanced-stage lung and breast cancers and lymphomas. More effective cancer vaccines are being developed through having a deeper understanding of crucial cellular factors in tumour immunology, the incorporation of newer vaccine components to effectively mobilise and activate cells, the use of omics and artificial intelligence in vaccine design, and addition of immune checkpoint blockade. In this Viewpoint, we analyse cancer vaccine trials, the strengths and limitations of different vaccine approaches, and we discuss how the next generation of cancer vaccines can help improve patient outcomes and quality of life.

239. Open letter in support of WHO.

作者: Ivana Bozicevic.;Stjepan Oreskovic.;Rieke van der Graaf.;Martin McKee.; .
来源: Lancet. 2025年405卷10497期2272-2273页

240. Challenges of the current yellow fever outbreak in Colombia.

作者: Carlos A Alvarez-Moreno.;Alfonso J Rodriguez-Morales.
来源: Lancet. 2025年405卷10497期2273页
共有 145288 条符合本次的查询结果, 用时 1.4800244 秒